Nxera Pharma Co., Ltd.
ネクセラファーマ株式会社
Ticker: 4565 · Updated Mar 25, 2026 16:01
Last Updated
Mar 25, 2026 16:01
Period:
Display Units:
Figures: No restatements in later reports
¥ millions · Annual
Tip: select a row to chart its trend.
Income Statement
Income Statement IFRS Consolidated | FY2016 Mar 31, 2017 Summary only | FY2017 Mar 31, 2018 Summary only | FY2018 (9 months) Dec 31, 2018 Summary only | FY2019 Dec 31, 2019 | FY2020 Dec 31, 2020 | FY2021 Dec 31, 2021 | FY2022 Dec 31, 2022 | FY2023 Dec 31, 2023 | FY2024 Dec 31, 2024 | FY2025 Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 18,901 | 6,955 | 2,872 | 9,726 | 8,842 | 17,712 | 15,569 | 12,766 | 28,835 | 29,615 | |
YoY Change | 131.9% | -63.2% | Year-over-year change is hidden because the two periods differ in length (the company changed its fiscal year-end). | Year-over-year change is hidden because the two periods differ in length (the company changed its fiscal year-end). | -9.1% | 100.3% | -12.1% | -18.0% | 125.9% | 2.7% |
| Not available | Not available | Not available | 851 | 761 | 933 | 926 | 3,102 | 7,616 | 8,198 | |
| Not available | Not available | Not available | 8,875 | 8,081 | 16,779 | 14,643 | 9,664 | 21,219 | 21,418 | |
YoY Change | Not available | Not available | Not available | Not available | -8.9% | 107.6% | -12.7% | -34.0% | 119.6% | 0.9% |
| Not available | Not available | Not available | 3,614 | 3,435 | 3,940 | 4,377 | 9,965 | 16,015 | 15,225 | |
| Not available | Not available | Not available | 37 | 79 | 8 | 626 | 944 | 1,289 | 1,656 | |
| Not available | Not available | Not available | 622 | 4 | 3,141 | 2 | 94 | 100 | 1,845 | |
| Not available | Not available | Not available | 384 | 928 | 3,775 | 3,436 | -9,526 | -5,423 | -8,462 | |
YoY Change | Not available | Not available | Not available | Not available | 141.7% | 306.8% | -9.0% | n/m: Not meaningful: the base period is a loss or zero, or the figure swung from a profit to a loss. | n/m: Not meaningful: the base period is a loss or zero, or the figure swung from a profit to a loss. | n/m: Not meaningful: the base period is a loss or zero, or the figure swung from a profit to a loss. |
| Not available | Not available | Not available | 824 | 1,628 | 199 | 663 | 1,341 | 1,544 | 987 | |
| Not available | Not available | Not available | 493 | 578 | 3,797 | 756 | 2,495 | 783 | 7,475 | |
| 12,483 | -3,702 | -7,243 | 534 | 1,622 | 433 | 1,078 | -10,680 | -4,662 | -14,950 | |
| -898 | 143 | -584 | 696 | -3,487 | 176 | -2,420 | ||||
| Not available | Not available | Not available | 1,432 | 1,479 | 1,017 | 382 | -7,193 | -4,838 | -12,530 | |
| 935 | -818 | 4,606 | -637 | 6,072 | 5,157 | 3,065 | ||||
| Not available | Not available | Not available | 2,367 | 661 | 5,623 | -255 | -1,121 | 319 | -9,466 |
Notes
- Figures in ¥ millions
- Financial data sourced from official Japanese regulatory disclosures
- Each column header links to its source filing; select a line to see its XBRL elements.
- Each year is shown as filed in that year's own report. Switch to Restated to see a year as the next year's report restated it; restated cells are marked R.
- Displaying 10 of 11 periods
- YoY Change compares each period with the same period a year earlier. A full year's change uses the prior year as that year's own report restates it (cells marked R), so it can differ from the change between the two columns as filed.
- Columns marked “Summary only”: for these years the filing tags only its summary of key figures (主要な経営指標等) in machine-readable form, as is usual for US-GAAP filers, so line items such as operating income are not available. The figures shown are the company’s own consolidated totals.
- FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Dec 2025) runs Jan 1, 2025 – Dec 31, 2025.
Get this data via the API
curl https://hachiquant.com/api/v1/companies/4565/income-statements?view=canonical curl https://hachiquant.com/api/v1/companies/4565/metrics No key needed. API reference